OBJECTIVES In the general population, increased afamin concentrations are associated with the prevalence and incidence of metabolic syndrome as well as type 2 diabetes. Although metabolic syndrome is commonly associated with nonalcoholic fatty liver disease (NAFLD), there exist no information on afamin and NAFLD. METHODS Afamin concentrations were cross-sectionally measured in 146 Austrian patients with NAFLD, in 45 patients without NAFLD, and in 292 age- and sex-matched healthy controls. Furthermore, the feasibility of afamin to predict incident NAFLD was evaluated in 1,434 adult participants in the population-based Cardiovascular Risk in Young Finns Study during a 10-year follow-up. RESULTS Median afamin concentrations were...
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is now the factor behind the development of liv...
Afamin is a protein in humans that plays a major role in the regulation of glucose metabolism, insul...
Screening for non-alcoholic fatty liver disease (NAFLD) is key step for primary management of fatty ...
ObjectivesIn the general population, increased afamin concentrations are associated with the prevale...
The human vitamin E-binding glycoprotein afamin is primarily expressed in the liver and has been ass...
OBJECTIVE The human vitamin E–binding glycoprotein afamin is primarily expressed in the liver and ha...
Backgrounds: The prevalence of NAFLD is increasing in the world. The mechanism of pathogenesis and s...
Nonalcoholic fatty liver disease (NAFLD) is becoming the most prevalent liver disease worldwide, ass...
Background: Serum concentrations of fetuin A/alpha 2HS-glycoprotein (AHSG) have been linked to human...
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide. It af...
Limited information exists on the impact of flavonoid intake on nonalcoholic fatty liver disease (NA...
Clinically, NAFLD is the most common cause of asymptomatic increases in transaminases. NAFLD is also...
nb pages:22International audienceBACKGROUND: Fatty liver is known to be linked with insulin resistan...
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) has been the most common cause of chronic live...
AbstractThe human glycoprotein afamin was discovered as the fourth member of the albumin gene family...
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is now the factor behind the development of liv...
Afamin is a protein in humans that plays a major role in the regulation of glucose metabolism, insul...
Screening for non-alcoholic fatty liver disease (NAFLD) is key step for primary management of fatty ...
ObjectivesIn the general population, increased afamin concentrations are associated with the prevale...
The human vitamin E-binding glycoprotein afamin is primarily expressed in the liver and has been ass...
OBJECTIVE The human vitamin E–binding glycoprotein afamin is primarily expressed in the liver and ha...
Backgrounds: The prevalence of NAFLD is increasing in the world. The mechanism of pathogenesis and s...
Nonalcoholic fatty liver disease (NAFLD) is becoming the most prevalent liver disease worldwide, ass...
Background: Serum concentrations of fetuin A/alpha 2HS-glycoprotein (AHSG) have been linked to human...
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide. It af...
Limited information exists on the impact of flavonoid intake on nonalcoholic fatty liver disease (NA...
Clinically, NAFLD is the most common cause of asymptomatic increases in transaminases. NAFLD is also...
nb pages:22International audienceBACKGROUND: Fatty liver is known to be linked with insulin resistan...
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) has been the most common cause of chronic live...
AbstractThe human glycoprotein afamin was discovered as the fourth member of the albumin gene family...
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is now the factor behind the development of liv...
Afamin is a protein in humans that plays a major role in the regulation of glucose metabolism, insul...
Screening for non-alcoholic fatty liver disease (NAFLD) is key step for primary management of fatty ...